Imagin Medical Inc. (IMEXF)

[Money $hot]

The news release from July 17. 2018:

“Imagin is grateful to the University of Rochester Medical Center for initiating and conducting this investigator-sponsored human research study,” commented Pam Papineau, Imagin’s Director of Regulatory and Clinical Affairs. “Imagin was pleased to provide early prototype equipment to assist the investigators in testing the underlying hypothesis that the i/Blue Imaging System can potentionally identify protoporphyrin IX (PpIX) fluorescence associated with bladder cancer lesions in the presence of the contrasting agent, hexaminolevulinate hydrochloride. This project was undertaken prior to the commencement of an FDA application, and provides important insights that will help guide the Company in an FDA-compliant process. Imagin anticipates initiating preliminary discussions with the FDA regarding the i/Blue Imaging System as soon as possible."

Fiscal Year End Report December 20, 2018:

“We continued to advance the development of the i/Blue Imaging System over the past year, hitting important milestones on the path to expected commercialization in 2020,” said Jim Hutchens, Imagin’s President and CEO. “Our focus for the first half of 2019 will be on completing the final product, initiating clinical studies and meeting with the FDA to define the i/Blue Imaging System’s regulatory pathway.”

I do not see the value in sticking around for another hypothetical timeline regarding a completed device and/or FDA clinical trial. The communications coming out of Imagin Medical are very suspect. I hate to say it, but the crazy poster here may well be right. This is shaping up to be an insider enrichment scheme.

GL2ALL

/////AMG